Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer. [electronic resource]
Producer: 20000407Description: 141-50 p. digitalISSN:- 0167-6806
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Drug Administration Schedule
- Electrocardiography
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Karnofsky Performance Status
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prospective Studies
- Spain -- epidemiology
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.